Citigroup’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $53.3M | Buy |
348,789
+277,455
| +389% | +$42.5M | 0.02% | 624 |
|
|
2025
Q4 | $9.83M | Sell |
71,334
-159,953
| -69% | -$20.9M | ﹤0.01% | 1546 |
|
|
2025
Q3 | $29.7M | Buy |
231,287
+17,266
| +8% | +$2.11M | 0.01% | 860 |
|
|
2025
Q2 | $25.9M | Sell |
214,021
-23,338
| -10% | -$2.63M | 0.01% | 844 |
|
|
2025
Q1 | $26.5M | Buy |
237,359
+21,023
| +10% | +$2.24M | 0.01% | 829 |
|
|
2024
Q4 | $21.1M | Sell |
216,336
-77,842
| -26% | -$8.3M | 0.01% | 930 |
|
|
2024
Q3 | $33.8M | Buy |
294,178
+42,642
| +17% | +$4.84M | 0.02% | 695 |
|
|
2024
Q2 | $26.8M | Sell |
251,536
-664,628
| -73% | -$66.7M | 0.02% | 764 |
|
|
2024
Q1 | $88.6M | Buy |
916,164
+676,034
| +282% | +$69.3M | 0.06% | 304 |
|
|
2023
Q4 | $24.2M | Buy |
240,130
+55,429
| +30% | +$5.35M | 0.02% | 757 |
|
|
2023
Q3 | $18.8M | Buy |
184,701
+725
| +0.4% | +$73.6K | 0.01% | 797 |
|
|
2023
Q2 | $18.6M | Sell |
183,976
-111,575
| -38% | -$11.2M | 0.01% | 858 |
|
|
2023
Q1 | $27.2M | Buy |
295,551
+119,005
| +67% | +$10.4M | 0.02% | 663 |
|
|
2022
Q4 | $16M | Buy |
176,546
+8,415
| +5% | +$709K | 0.01% | 894 |
|
|
2022
Q3 | $12.8M | Buy |
168,131
+1,420
| +0.9% | +$118K | 0.01% | 1017 |
|
|
2022
Q2 | $14.1M | Buy |
166,711
+245
| +0.1% | +$21.5K | 0.01% | 971 |
|
|
2022
Q1 | $14.6M | Buy |
166,466
+12,745
| +8% | +$1.1M | 0.01% | 1103 |
|
|
2021
Q4 | $13.4M | Sell |
153,721
-42,016
| -21% | -$3.49M | 0.01% | 1218 |
|
|
2021
Q3 | $16M | Sell |
195,737
-90,610
| -32% | -$8.15M | 0.01% | 1134 |
|
|
2021
Q2 | $26.1M | Buy |
286,347
+10,830
| +4% | +$964K | 0.02% | 846 |
|
|
2021
Q1 | $23.6M | Buy |
275,517
+46,968
| +21% | +$4.21M | 0.02% | 870 |
|
|
2020
Q4 | $21.6M | Buy |
228,549
+8,485
| +4% | +$741K | 0.01% | 988 |
|
|
2020
Q3 | $19.1M | Buy |
220,064
+521
| +0.2% | +$45.1K | 0.01% | 925 |
|
|
2020
Q2 | $19.2M | Sell |
219,543
-30,405
| -12% | -$2.62M | 0.02% | 852 |
|
|
2020
Q1 | $20.6M | Buy |
249,948
+11,950
| +5% | +$1.07M | 0.02% | 716 |
|
|
2019
Q4 | $22.5M | Buy |
237,998
+83,986
| +55% | +$7.54M | 0.02% | 899 |
|
|
2019
Q3 | $13.4M | Sell |
154,012
-131,815
| -46% | -$11.8M | 0.01% | 1186 |
|
|
2019
Q2 | $26.1M | Buy |
285,827
+16,207
| +6% | +$1.37M | 0.02% | 785 |
|
|
2019
Q1 | $23.2M | Buy |
269,620
+129,389
| +92% | +$10.4M | 0.02% | 746 |
|
|
2018
Q4 | $10.8M | Sell |
140,231
-195
| -0.1% | -$15.2K | 0.01% | 1206 |
|
|
2018
Q3 | $10.8M | Buy |
140,426
+7,776
| +6% | +$575K | 0.01% | 1231 |
|
|
2018
Q2 | $8.98M | Sell |
132,650
-62,345
| -32% | -$4.3M | 0.01% | 1366 |
|
|
2018
Q1 | $14.2M | Buy |
194,995
+46,921
| +32% | +$3.57M | 0.01% | 1005 |
|
|
2017
Q4 | $11.1M | Sell |
148,074
-27,998
| -16% | -$2.11M | 0.01% | 1214 |
|
|
2017
Q3 | $13.5M | Buy |
176,072
+37,419
| +27% | +$2.83M | 0.01% | 1027 |
|
|
2017
Q2 | $10.4M | Buy |
138,653
+26,641
| +24% | +$1.89M | 0.01% | 1120 |
|
|
2017
Q1 | $7.45M | Sell |
112,012
-70,105
| -38% | -$4.67M | 0.01% | 1351 |
|
|
2016
Q4 | $11.9M | Buy |
182,117
+35,956
| +25% | +$2.33M | 0.01% | 1073 |
|
|
2016
Q3 | $10.3M | Sell |
146,161
-29,476
| -17% | -$2.15M | 0.01% | 1061 |
|
|
2016
Q2 | $13M | Sell |
175,637
-6,330
| -3% | -$437K | 0.01% | 871 |
|
|
2016
Q1 | $11.8M | Sell |
181,967
-4,669
| -3% | -$318K | 0.01% | 889 |
|
|
2015
Q4 | $14.4M | Buy |
186,636
+31,663
| +20% | +$2.52M | 0.01% | 915 |
|
|
2015
Q3 | $12.8M | Buy |
154,973
+49,539
| +47% | +$4.41M | 0.01% | 985 |
|
|
2015
Q2 | $9.29M | Buy |
105,434
+6,521
| +7% | +$598K | 0.01% | 1253 |
|
|
2015
Q1 | $8.74M | Sell |
98,913
-102,779
| -51% | -$9.12M | 0.01% | 1280 |
|
|
2014
Q4 | $16.7M | Sell |
201,692
-26,421
| -12% | -$2.19M | 0.02% | 906 |
|
|
2014
Q3 | $19.2M | Buy |
228,113
+6,898
| +3% | +$558K | 0.02% | 832 |
|
|
2014
Q2 | $17.9M | Buy |
221,215
+43,768
| +25% | +$3.44M | 0.02% | 859 |
|
|
2014
Q1 | $13.5M | Buy |
177,447
+30,555
| +21% | +$2.23M | 0.01% | 963 |
|
|
2013
Q4 | $10.6M | Buy |
146,892
+7,596
| +5% | +$528K | 0.01% | 1195 |
|
|
2013
Q3 | $9.57M | Buy |
139,296
+13,615
| +11% | +$901K | 0.01% | 1204 |
|
|
2013
Q2 | $7.96M | Buy |
+125,681
| New | +$8.18M | 0.01% | 1249 |
|
Other funds holding NVS
Citigroup's NVS Position: Q1 2026 in Review
Citigroup increased its Novartis (NVS) stake by 389% in Q1 2026, buying an estimated $42.5M and bringing the position to 348,789 shares worth $53.3M. The position accounts for 0.02% of the portfolio, ranked #624.
Citigroup first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $88.6M in Q1 2024. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Citigroup held 348,789 shares of Novartis worth $53.3M as of Q1 2026.
- Citigroup bought 277,455 Novartis shares in Q1 2026, an estimated $42.5M.
- Novartis made up 0.02% of Citigroup's portfolio in Q1 2026, its #624 holding.
- Citigroup first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Novartis position peaked at $88.6M in Q1 2024.
- 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.